Skip to main content
Tiziana Life Sciences Ltd logo

Tiziana Life Sciences Ltd — Investor Relations & Filings

Ticker · TLSA ISIN · BMG889121031 LEI · 984500769407C5E46F42 US Professional, scientific and technical activities
Open in API
Filings indexed 460 across all filing types
Latest filing 2023-03-08 Regulatory Filings
Country BM Bermuda
Listing US TLSA

About Tiziana Life Sciences Ltd

https://www.tizianalifesciences.com/

Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company focused on developing innovative immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's core strategy involves utilizing alternative drug delivery routes, such as intranasal administration, to modulate the immune system. Its lead clinical candidate, foralumab (TZLS-401), is the only fully human anti-CD3 monoclonal antibody being investigated for neurological conditions. Foralumab is in clinical development for the treatment of Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS), Alzheimer's disease, Amyotrophic Lateral Sclerosis (ALS), and Multiple System Atrophy (MSA). The company's pipeline also includes an anti-IL-6 receptor monoclonal antibody (TZLS-501) for potential application in lung diseases.

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains an announcement about a press release regarding a publication in a scientific journal. The document is short (2884 characters) and primarily serves to furnish information rather than provide detailed financial data or comprehensive reports. It explicitly states that the information is furnished and not filed, indicating it is an announcement rather than a full report. There is no substantive financial data or detailed analysis present. Therefore, this document fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings and announcements that do not fit other specific categories.
2023-03-08 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Tiziana Life Sciences LTD, pursuant to the SEC rules. It announces the release of an updated corporate deck available on the company's website. The document is short (2946 characters) and primarily serves as an announcement of the release of a presentation rather than containing the presentation or detailed financial data itself. It does not contain financial statements or substantive financial analysis. Therefore, it is not an Annual Report, Interim Report, or Earnings Release. It is also not a certification or legal proceeding. The document fits the description of a Regulatory Filing (RNS) as a general regulatory announcement that does not fit into other specific categories.
2023-01-05 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains an announcement about a press release regarding the filing of an IND for a Phase 2 study. The document is short (2866 characters) and primarily serves to furnish information rather than provide detailed financial data or a full report. It explicitly states that the information is furnished and not filed for certain regulatory purposes. There are no financial statements or substantive financial analysis present. This aligns with the characteristics of a Regulatory Filing (RNS) as a general regulatory announcement and miscellaneous filing that does not fit other categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-01-04 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It contains a press release announcement about clinical improvements related to the company's product. The document is short (3003 characters) and primarily serves to furnish information rather than provide detailed financial data or comprehensive reports. It explicitly states that the information is furnished and not filed, indicating it is an announcement rather than a full report. There are no financial statements or detailed analysis present. Therefore, this document fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous filings and announcements that do not fit other specific categories.
2023-01-03 English
REPORT OF FOREIGN PRIVATE ISSUER
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, Tiziana Life Sciences LTD, pursuant to SEC rules. It includes a press release reporting financial results for the six-month period ended June 30, 2022, and consolidated financial statements for the same period. The document length is 3230 characters, which is relatively short and the text states that the financial results and statements are furnished as exhibits. This indicates the document is a current report furnishing information rather than a full interim or quarterly report itself. Form 6-K filings typically serve as regulatory filings to update the market on material events between annual reports. Therefore, this document fits best under Regulatory Filings (RNS) rather than Interim/Quarterly Report (IR) because it is a Form 6-K and the actual financial statements are exhibits, not embedded full reports. Confidence is high due to clear SEC form identification and content description.
2022-12-30 English
REPORT OF FOREIGN PRIVATE ISSUER
AGM Information Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It specifically states that it contains a press release reporting the results of the Annual General Meeting (AGM). The document itself is short (2875 characters) and primarily serves to furnish the AGM results announcement as Exhibit 99.1. It does not contain the full AGM materials or detailed financial reports but rather an announcement related to the AGM results. According to the classification rules, such a document is best classified as AGM Information (AGM-R) because it relates to the AGM and contains materials shared during that meeting, not a full annual report or other filings.
2022-12-29 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.